2Rockwood K,Wentzel C,Hachinski V,et al.Prevalence and outcomesof vascular cognitive impairment.Vascular Cognitive ImpairmentInvestigators of the Canadian Study of Health and Aging[J]. Neurology,2000,54(2):447-451.
5Sudhir K. Memantine: Pharmacological properties and clinical uses.Neurol India, 2004, 52:307-309.
6Orgogozo JM, Rigaud AS, St? ffler A, et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke, 2002, 33:1834-1839.
7Wilcock G, Mobius HJ, Stoffler A, et al. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol, 2002, 17:297-305.
8Areosa Sastre A, McShane R, Sherriff F. Memantine for dementia. Cochrane Database Syst Rev, 2004, 18: CD003154.
9doody RS, Stevens JC, Beck C, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001,56, 1154-1166.
10Pohjasvaara T, Mantyla R, Ylikoski R, et al. Comparison of different clinical criteria (DSM-Ⅲ, ADDTC, ICD-10, NINDS-AIREN, DSM-Ⅳ)for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences. Stroke, 2000, 31: 2952-2957.
4Gorelick PB,Bowler JV. Advances in vascular cognitive impairment[J].STROKE,2010,(02):93-98.
5Kalaria RN,Kenny RA,Ballard CG. Towards defining the neuro-pathological substrates of vascular dementia[J].Journal of the Neurological Sciences,2004,(1/2):75-85.
6Pendlebury ST,Rothwell PM. Risk of recurrent stroke,other vascular e-vents and dementia after transient ischaemic attack and stroke[J].Cere-brovasc Dis,2009,(03):1-11.
7Cordeiro Q,Nognti R,Bottino CM. Study of association between genetic polymorphisms of phospholipase A2 enzymes and Alzheimer′S disease[J].Arquivos de Neuro-Psiquiatria,2010,(02):189-193.
8Masafumi Ihara,Yoko Okamoto,Ryosuke Takahashi.Suitability of the Montreal Cognitive Assessment versus the Mini-Mental State Examination in Detecting Vascular Cognitive Impairment[J]. Journal of Stroke and Cerebrovascular Diseases . 2012
9Epps KC, Wilensky RL. Lp-PLA2-a novel risk factor for high risk coro-nary and carotid artery disease. J Intern Med,2011,269:94-106.
10Pantoni L,Gorelick P. Advances in vascular cognitive impairment 2010.Stroke,2011,42:291-293.
